{"id":"non-arb","safety":{"commonSideEffects":[]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Without access to detailed pharmacological data on this specific compound, the exact mechanism cannot be reliably determined. The designation 'Non-ARB' suggests it is distinct from angiotensin II receptor blockers, but the actual molecular target and therapeutic mechanism remain unclear from available public information.","oneSentence":"Non-ARB is a non-angiotensin II receptor blocker compound developed at Kyoto Prefectural University of Medicine with an undisclosed mechanism of action.","_ai_confidence":"low"},"_scrapedAt":"2026-03-27T23:57:37.737Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[]},"trialDetails":[{"nctId":"NCT07483151","phase":"","title":"Venous Congestion And Cognitive Dysfunction After Cardiac Surgery","status":"RECRUITING","sponsor":"Zhuan Zhang","startDate":"2024-11-01","conditions":"Intraoperative Venous Congestion And Cognitive Dysfunction After Cardiac Surgery","enrollment":110},{"nctId":"NCT04649229","phase":"PHASE4","title":"Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 3","status":"COMPLETED","sponsor":"Yale University","startDate":"2021-05-27","conditions":"Heart Failure","enrollment":46},{"nctId":"NCT04789733","phase":"NA","title":"The GUARDIAN Pilot Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2021-04-27","conditions":"General Surgery","enrollment":80},{"nctId":"NCT06975111","phase":"PHASE2, PHASE3","title":"Focusing on the Menopausal Transition to Improve Mid-Life Women's Health","status":"NOT_YET_RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2026-03-01","conditions":"Menopause, Menopause Hot Flashes, Menopause Related Conditions","enrollment":200},{"nctId":"NCT07447206","phase":"PHASE2","title":"Vascular Intervention Strategies Trial for Alzheimer's","status":"NOT_YET_RECRUITING","sponsor":"University of Southern California","startDate":"2026-03","conditions":"Hypertension, Hypercholesterolemia, Dementia Risk Factors","enrollment":10},{"nctId":"NCT07167368","phase":"NA","title":"Exercise Rehabilitation for Cardiorenal Syndrome in HFrEF Patients","status":"RECRUITING","sponsor":"Haiyan Pan","startDate":"2025-09-15","conditions":"Cardiorenal Syndrome","enrollment":60},{"nctId":"NCT03417388","phase":"PHASE4","title":"Women's IschemiA TRial to Reduce Events In Non-ObstRuctive CAD","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Florida","startDate":"2018-02-09","conditions":"Coronary Artery Disease","enrollment":2476},{"nctId":"NCT07044700","phase":"","title":"Real-world Comparative Effectiveness and Safety of Jardiance in Chinese Patients With Heart Failure of Reduced Ejection Fraction","status":"NOT_YET_RECRUITING","sponsor":"Boehringer Ingelheim","startDate":"2028-01-31","conditions":"Heart Failure of Reduced Ejection Fraction (HFrEF)","enrollment":5000},{"nctId":"NCT06526195","phase":"NA","title":"Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure","status":"RECRUITING","sponsor":"Abbott Medical Devices","startDate":"2024-12-13","conditions":"Heart Failure, Heart Diseases, Cardiovascular Diseases","enrollment":850},{"nctId":"NCT06643676","phase":"NA","title":"Effect of Targeted Endodontic Microsurgery on Quality of Life and Healing on Mandibular Molars","status":"COMPLETED","sponsor":"Postgraduate Institute of Dental Sciences Rohtak","startDate":"2024-07-01","conditions":"Periapical Diseases, Periapical Periodontitis, Periapical Cyst","enrollment":50},{"nctId":"NCT07376265","phase":"","title":"A Real-world Study to Compare the Effectiveness of Sacubitril/Valsartan Versus ACEi/ARB in HFrEF Patients","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2023-10-20","conditions":"Heart Failure","enrollment":1249},{"nctId":"NCT04591210","phase":"PHASE3","title":"The COVID-RASi Trial (COVID-19)","status":"COMPLETED","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2021-01-27","conditions":"COVID-19, Cardiovascular Diseases","enrollment":372},{"nctId":"NCT07348718","phase":"","title":"Rubix LS Diabetic Kidney Disease (DKD) Registry Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Rubix LS","startDate":"2025-12-15","conditions":"Diabetic Kidney Disease (DKD)","enrollment":2000},{"nctId":"NCT06029712","phase":"PHASE2","title":"Heart Failure Polypill at a Safety Net Hospital","status":"COMPLETED","sponsor":"University of California, San Francisco","startDate":"2024-02-27","conditions":"Heart Failure With Reduced Ejection Fraction, HIV Infections","enrollment":35},{"nctId":"NCT07285187","phase":"","title":"Venous Congestion And Delirium After Cardiac Surgery","status":"RECRUITING","sponsor":"Zhuan Zhang","startDate":"2024-11-01","conditions":"Intraoperative, Venous Congestion, Postoperative Delirium (POD)","enrollment":120},{"nctId":"NCT05106036","phase":"NA","title":"Preventing Cognitive Decline by Reducing BP Target Trial","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2022-07-11","conditions":"Cognitive Decline, Blood Pressure, Hypertension","enrollment":4000},{"nctId":"NCT06183437","phase":"PHASE4","title":"The STOP-MED CTRCD Trial","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2024-03-04","conditions":"Heart Failure, Cardiotoxicity, Cardiac Toxicity","enrollment":335},{"nctId":"NCT07232277","phase":"","title":"Venous Congestion and Cardiac Surgery-Associated Acute Kidney Injury","status":"RECRUITING","sponsor":"Zhuan Zhang","startDate":"2024-10-15","conditions":"Intraoperative, Venous Congestion, Cardiac Surgery-associated Acute Kidney Injury","enrollment":114},{"nctId":"NCT06862115","phase":"PHASE3","title":"The Effect of Discontinuation of Renin Angiotensin System Inhibitors on the Perioperative Myocardial Injury in Adult Patients Undergoing Colorectal Cancer Surgery","status":"RECRUITING","sponsor":"Kasr El Aini Hospital","startDate":"2025-03-01","conditions":"Myocardium; Injury, Perioperative/Postoperative Complications, Angiotensin-Converting-Enzyme Inhibitor","enrollment":156},{"nctId":"NCT06697353","phase":"","title":"An Observational Study to Learn More About the Real-world Outcomes in Patients With Heart Failure Who Initiate Treatment With Vericiguat in Japan","status":"COMPLETED","sponsor":"Bayer","startDate":"2024-11-01","conditions":"Chronic Heart Failure, Chronic Heart Failure With Reduced Ejection Fraction","enrollment":4936},{"nctId":"NCT03418961","phase":"PHASE3","title":"S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity","status":"RECRUITING","sponsor":"SWOG Cancer Research Network","startDate":"2017-11-01","conditions":"Cardiotoxicity, HER2/Neu Positive, Metastatic Malignant Neoplasm in the Brain","enrollment":491},{"nctId":"NCT05180773","phase":"PHASE4","title":"Impact of Bromocriptine on Clinical Outcomes for Peripartum Cardiomyopathy","status":"RECRUITING","sponsor":"Dennis M. McNamara, MD, MS","startDate":"2022-07-27","conditions":"Peripartum Cardiomyopathy, Postpartum","enrollment":250},{"nctId":"NCT05272878","phase":"PHASE3","title":"Impact of a Treatment With Angiotensin Receptor Blocker on Outcome After Acute Kidney Injury in Patients Discharged From the ICU.","status":"ACTIVE_NOT_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2022-11-22","conditions":"Acute Kidney Injury","enrollment":508},{"nctId":"NCT04884802","phase":"NA","title":"The GUARDIAN Trial","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2021-07-25","conditions":"Blood Pressure","enrollment":6254},{"nctId":"NCT04113109","phase":"PHASE4","title":"Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2019-11-01","conditions":"Heart Failure","enrollment":46},{"nctId":"NCT03476616","phase":"PHASE4","title":"Antihypertensive Pharmacological Therapy With Mineralocorticoid Receptor Antagonists in Obese Hypertensive Patients","status":"COMPLETED","sponsor":"Hippocration General Hospital","startDate":"2018-09-01","conditions":"Hypertension, Obesity","enrollment":198},{"nctId":"NCT05790668","phase":"NA","title":"Motivational Refinements for Facilitating Reinforcement Schedule Thinning","status":"RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2023-10-24","conditions":"Decreasing Destructive Behavior, Increasing Functional Communicative Behavior","enrollment":30},{"nctId":"NCT06676384","phase":"PHASE4","title":"Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?","status":"RECRUITING","sponsor":"Christian Medical College, Vellore, India","startDate":"2025-02-15","conditions":"IgA Nephropathy, Renal Insufficiency, Chronic, IgA Vasculitis","enrollment":585},{"nctId":"NCT07032116","phase":"","title":"YiqiJiangzhuoHuoxueTongluo Method to Delay the Occurrence of End-stage Renal Disease in Diabetic Kidney Disease--Study1","status":"NOT_YET_RECRUITING","sponsor":"Liu Hongfang","startDate":"2025-08-01","conditions":"Diabetic Kidney Disease (DKD)","enrollment":4472},{"nctId":"NCT06143566","phase":"PHASE1, PHASE2","title":"Polypill for Prevention of Cardiomyopathy","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2024-03-11","conditions":"Type 2 Diabetes, High Blood Pressure","enrollment":200},{"nctId":"NCT04899206","phase":"","title":"ANGIOTENSIN AGENTS AND REDUCTION OF THE PRESCRIPTION OF ANTIDEPRESSANT DRUGS: A RETROSPECTIVE COHORT STUDY USING REAL-WORLD DATA","status":"WITHDRAWN","sponsor":"Sebastian Videla","startDate":"2021-04-12","conditions":"ACE Inhibitors, ARB, Hypertension","enrollment":""},{"nctId":"NCT06964217","phase":"","title":"Immediate Fracture Risk After Antihypertensive Drug Initiation","status":"NOT_YET_RECRUITING","sponsor":"Ajou University School of Medicine","startDate":"2025-06-01","conditions":"Hypertension, Fracture","enrollment":10000000},{"nctId":"NCT05572957","phase":"NA","title":"LBBP as Initial Therapy in Patients With Non-ischemic Heart Failure and LBBB","status":"RECRUITING","sponsor":"The First Affiliated Hospital with Nanjing Medical University","startDate":"2022-10-14","conditions":"Non-ischemic Cardiomyopathy, Heart Failure, Left Bundle-Branch Block","enrollment":50},{"nctId":"NCT00429364","phase":"PHASE3","title":"Comparison of Two Medications Aimed at Slowing Aortic Root Enlargement in Individuals With Marfan Syndrome","status":"COMPLETED","sponsor":"Carelon Research","startDate":"2007-01","conditions":"Marfan Syndrome","enrollment":608},{"nctId":"NCT06450522","phase":"NA","title":"Post-Discharge Pharmacist-led Rapid Medication Optimization for Heart Failure (Post-Discharge PHARM-HF)","status":"TERMINATED","sponsor":"University of British Columbia","startDate":"2024-07-04","conditions":"Heart Failure with Reduced Ejection Fraction HFrEF","enrollment":12},{"nctId":"NCT06012487","phase":"PHASE1","title":"Correlates and Control of Blood Pressure Variability","status":"NOT_YET_RECRUITING","sponsor":"Cedars-Sinai Medical Center","startDate":"2026-05-01","conditions":"Blood Pressure Variability","enrollment":10},{"nctId":"NCT04768322","phase":"NA","title":"LVAD Versus GDMT in Ambulatory Advanced Heart Failure Patients","status":"RECRUITING","sponsor":"Hospices Civils de Lyon","startDate":"2021-02-24","conditions":"End-stage Heart Failure","enrollment":92},{"nctId":"NCT06711432","phase":"NA","title":"Different Intraoperative Blood Pressure Management on Postoperative Cognitive Function in Tumor Patients（PRECISION）","status":"RECRUITING","sponsor":"Zhejiang Cancer Hospital","startDate":"2024-09-18","conditions":"Tumor, Stroke","enrollment":214},{"nctId":"NCT05897372","phase":"PHASE2","title":"Feasibility of Aggressive Albuminuria Reduction in Biopsy-Proven Diabetic Nephropathy - a Pilot Study","status":"TERMINATED","sponsor":"Iain Bressendorff","startDate":"2023-08-01","conditions":"Diabetic Kidney Disease","enrollment":1},{"nctId":"NCT05824923","phase":"PHASE3","title":"A Trial to Evaluate the Safety and Efficacy of Pulmonary Artery Denervation for the Treatment of Pulmonary Hypertension Associated With Left Heart Failure","status":"RECRUITING","sponsor":"Pulnovo Medical (Wuxi) Co., Ltd.","startDate":"2023-08-14","conditions":"Pulmonary Hypertension, Heart Failure With Reduced Ejection Fraction, Hypertension","enrollment":264},{"nctId":"NCT05164653","phase":"PHASE4","title":"Program of Angiotensin-Neprilysin Inhibition in Admitted Patients With Worsening Heart Failure (PREMIER)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Saga University","startDate":"2021-12-27","conditions":"Heart Failure","enrollment":400},{"nctId":"NCT06344910","phase":"","title":"PRagmatic Study Of Messaging to Providers of Patients With Heart Failure in Amsterdam UMC","status":"RECRUITING","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2024-05-21","conditions":"Heart Failure With Reduced Ejection Fraction","enrollment":900},{"nctId":"NCT06515678","phase":"","title":"Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension","status":"ACTIVE_NOT_RECRUITING","sponsor":"Groupe Hospitalier Pitie-Salpetriere","startDate":"2024-05-20","conditions":"Ovarian Cancer, Antiangiogenic-Associated Hypertension, Adjuvant Bevacizumab","enrollment":9464},{"nctId":"NCT05122780","phase":"PHASE4","title":"Prognostic Value of Precision Medicine in Patients With MINOCA (PROMISE Trial).","status":"ACTIVE_NOT_RECRUITING","sponsor":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","startDate":"2021-07-01","conditions":"Myocardial Infarction With Non-Obstructive Coronary Arteries","enrollment":120},{"nctId":"NCT06501651","phase":"PHASE4","title":"Sacubitril/Valsartan Treats Patients With Essential Hypertension and Type 2 Diabetic Nephropathy","status":"NOT_YET_RECRUITING","sponsor":"Sichuan Academy of Medical Sciences","startDate":"2024-08-01","conditions":"Essential Hypertension, Type 2 Diabetes, Nephropathy","enrollment":297},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT06405100","phase":"PHASE3","title":"Efficacy and Safety of Tacrolimus in Combination With Ripertamab in the Initial Treatment of Patients With MCD","status":"NOT_YET_RECRUITING","sponsor":"Air Force Military Medical University, China","startDate":"2024-05","conditions":"Minimal Change Disease","enrollment":81},{"nctId":"NCT06395194","phase":"PHASE3","title":"Effects of Valsartan vs Amlodipine and Low BP on Kidney Outcomes in Essential Hypertension","status":"COMPLETED","sponsor":"Oslo University Hospital","startDate":"1997-09-27","conditions":"Essential Hypertension","enrollment":15313},{"nctId":"NCT04032587","phase":"NA","title":"Modification of Pavlovian and Instrumental Learning in Human Addiction","status":"COMPLETED","sponsor":"Charite University, Berlin, Germany","startDate":"2019-10-01","conditions":"Healthy, Alcohol Use Disorder (Mild vs. Moderate to Heavy)","enrollment":80},{"nctId":"NCT06176599","phase":"NA","title":"Clinical Study on the Treatment of Diabetic Kidney Disease With Shenxiao Yuning Decoction With Syndrome of Qi and Yin Deficiency and Blood Stasis","status":"UNKNOWN","sponsor":"Lin Liao","startDate":"2022-09-01","conditions":"Diabetic Kidney Disease","enrollment":60},{"nctId":"NCT06175663","phase":"","title":"Hyperintense: Midlife Hypertension and the Brain","status":"UNKNOWN","sponsor":"Radboud University Medical Center","startDate":"2021-07-06","conditions":"Hypertension, Small Vessel Cerebrovascular Disease","enrollment":130},{"nctId":"NCT04819763","phase":"NA","title":"Physical Exercises for Temporomandibular Disorders","status":"COMPLETED","sponsor":"University Medicine Greifswald","startDate":"2021-05-03","conditions":"Facial Pain, Temporomandibular Disorder, Temporomandibular Joint Disorders","enrollment":60},{"nctId":"NCT03957161","phase":"NA","title":"ACEi ARB Withdrawal in CKD Patients","status":"WITHDRAWN","sponsor":"University of California, San Francisco","startDate":"2023-11","conditions":"Chronic Kidney Disease, Blood Pressure, Angiotensin-converting Enzyme Inhibitor","enrollment":""},{"nctId":"NCT03951142","phase":"PHASE2","title":"Imaging Perfusion Restrictions From Extracellular Solid Stress - An Open-label Losartan Study","status":"UNKNOWN","sponsor":"Kyrre Eeg Emblem","startDate":"2019-10-01","conditions":"Glioblastoma, Brain Metastases","enrollment":165},{"nctId":"NCT06039072","phase":"","title":"Clinical Observation of Long-term Cardiac Function Prognosis in Patients With PPCM Who Have Recovered Cardiac Function","status":"UNKNOWN","sponsor":"Qilu Hospital of Shandong University","startDate":"2023-10-10","conditions":"Cardiomyopathy, Dilated","enrollment":120},{"nctId":"NCT05966818","phase":"PHASE4","title":"Effect of Dapagliflozin in Non-Diabetic Patients With Nephrotic Syndrome.","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2023-08-01","conditions":"Nephrotic Syndrome","enrollment":90},{"nctId":"NCT05948969","phase":"NA","title":"Transform CV Risk in Diabetes","status":"UNKNOWN","sponsor":"American College of Cardiology","startDate":"2023-09-01","conditions":"Type 2 Diabetes","enrollment":750},{"nctId":"NCT04474704","phase":"NA","title":"Use of Cheetah® Cardiac Monitoring System to Guide Discontinuation of Magnesium Sulfate in Women With Severe Preeclampsia","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2021-02-22","conditions":"Preeclampsia With Severe Features","enrollment":53},{"nctId":"NCT05007262","phase":"PHASE2","title":"Tangningtongluo Tablet in the Treatment of Non-proliferative Diabetic Retinopathy","status":"UNKNOWN","sponsor":"Guizhou Bailing Group Pharmaceutical Co Ltd","startDate":"2021-08-31","conditions":"Type2 Diabetes, Diabetic Retinopathy","enrollment":240},{"nctId":"NCT05841654","phase":"PHASE4","title":"Effect of Azilsartan on Atrial Fibrillation in Patients With Hypertension","status":"UNKNOWN","sponsor":"Beijing Tsinghua Chang Gung Hospital","startDate":"2023-06-01","conditions":"Hypertension, Atrial Fibrillation","enrollment":400},{"nctId":"NCT01233635","phase":"PHASE4","title":"Secondary Prevention of Atrial Fibrillation (Impact of Renin-Angiotensin-Aldosterone System Inhibition)","status":"TERMINATED","sponsor":"University of Pittsburgh","startDate":"2005-11","conditions":"Atrial Fibrillation","enrollment":228},{"nctId":"NCT05243199","phase":"PHASE4","title":"Sacubitril/Valsartan for CKD5 Stage Dialysis Patients","status":"COMPLETED","sponsor":"Ruijin Hospital","startDate":"2020-08-01","conditions":"CKD5 Stage Dialysis, Heart Failure","enrollment":330},{"nctId":"NCT02188121","phase":"PHASE4","title":"Fixed Dose Intervention Trial of New England Enhancing Survival in SMI Patients","status":"COMPLETED","sponsor":"Mclean Hospital","startDate":"2015-02","conditions":"Serious Mental Illness, Schizophrenia, Schizoaffective Disorder","enrollment":227},{"nctId":"NCT04351581","phase":"NA","title":"Effects of Discontinuing Renin-angiotensin System Inhibitors in Patients With and Without COVID-19","status":"COMPLETED","sponsor":"University Hospital, Gentofte, Copenhagen","startDate":"2020-05-18","conditions":"Covid-19","enrollment":78},{"nctId":"NCT05633758","phase":"PHASE2","title":"Metolazone As Early Add On Therapy For Acute Decompensated Heart Failure","status":"WITHDRAWN","sponsor":"Scripps Health","startDate":"2014-03","conditions":"Acute Decompensated Heart Failure","enrollment":""},{"nctId":"NCT04848727","phase":"","title":"Detection of Atelectasis or Pneumothorax and Resolution With Electrical Impedance Tomography (EIT) in Newborn Infants","status":"COMPLETED","sponsor":"Sharp HealthCare","startDate":"2021-08-06","conditions":"Atelectasis Neonatal, Pneumothorax and Air Leak","enrollment":20},{"nctId":"NCT04129840","phase":"NA","title":"Identifying Most Effective Treatment Strategies to Control Arterial Hypertension in Sub-Saharan Africa","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2020-03-05","conditions":"Arterial Hypertension","enrollment":1268},{"nctId":"NCT05398731","phase":"","title":"Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Risk of COVID_19","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2022-06","conditions":"COVID-19 Pneumonia","enrollment":400},{"nctId":"NCT00541268","phase":"NA","title":"Efficacy of Implantable Cardioverter Defibrillator in Patients With Non-ischemic Systolic Heart Failure on Mortality","status":"COMPLETED","sponsor":"Danish Study Group","startDate":"2008-02","conditions":"Heart Failure, Dilated Cardiomyopathy, Reduced LVEF","enrollment":1116},{"nctId":"NCT03529838","phase":"NA","title":"Hemodynamic and Salivary Responses of 12 Weeks of Training With Different Anti-hypertensive","status":"TERMINATED","sponsor":"Federal University of Uberlandia","startDate":"2017-03-01","conditions":"Hypertension, Menopause","enrollment":30},{"nctId":"NCT05232370","phase":"PHASE2","title":"The Effect of Enalapril, Losartan or Not Antihypertensive on the Oxidative Status in Renal Transplant Recipients","status":"COMPLETED","sponsor":"Unidad de Investigacion Medica en Enfermedades Renales","startDate":"2022-01-01","conditions":"Oxidative Stress","enrollment":39},{"nctId":"NCT05096039","phase":"","title":"Role of Sacubitril/Valsartan in Improving Provider Performance in Managing Heart Failure Under Medicare Alternative Payment Models","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2020-04-10","conditions":"Heart Failure","enrollment":1614719},{"nctId":"NCT01091961","phase":"NA","title":"Study of Preoperative Management of Angiotensin Converting Enzyme Inhibitor (ACEi) and Angiotensin Receptor Blocker (ARB) Medications","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2010-01","conditions":"Hypertension","enrollment":200},{"nctId":"NCT01508468","phase":"PHASE3","title":"Evaluate Rituximab Treatment for Idiopathic Membranous Nephropathy","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2012-01-17","conditions":"Idiopathic Membranous Nephropathy","enrollment":80},{"nctId":"NCT02471599","phase":"NA","title":"Effect of Tonsillectomy on Longterm Renal Outcome of IgA Nephropathy","status":"SUSPENDED","sponsor":"Sun Yat-sen University","startDate":"2011-03","conditions":"IgA Nephropathy","enrollment":100},{"nctId":"NCT04191681","phase":"PHASE4","title":"Safety and Efficacy of ARNI After LVAD ImplanT (SEAL-IT) Study","status":"RECRUITING","sponsor":"The Cleveland Clinic","startDate":"2019-11-08","conditions":"Stage D Heart Failure","enrollment":50},{"nctId":"NCT01705080","phase":"","title":"IntErnational Long-term Follow-up Study of Patients With Uncontrolled HyperTensioN","status":"TERMINATED","sponsor":"Abbott Medical Devices","startDate":"2013-01-17","conditions":"Hypertension, Blood Pressure","enrollment":276},{"nctId":"NCT04340557","phase":"PHASE4","title":"Do Angiotensin Receptor Blockers Mitigate Progression to Acute Respiratory Distress Syndrome With SARS-CoV-2 Infection","status":"COMPLETED","sponsor":"Sharp HealthCare","startDate":"2020-03-27","conditions":"SARS-CoV Infection","enrollment":31},{"nctId":"NCT04141800","phase":"","title":"Spanish Study of Hyperkalaemia Incidence and Prognosis in Patients With Heart Failure and Reduced Ejection Fraction","status":"COMPLETED","sponsor":"Spanish Society of Cardiology","startDate":"2019-04-30","conditions":"Heart Failure With Reduced Ejection Fraction, Hyperkalemia","enrollment":565},{"nctId":"NCT02488252","phase":"PHASE2, PHASE3","title":"Semi-individualised Chinese Medicine Treatment as an Adjuvant Management for Diabetic Nephropathy","status":"UNKNOWN","sponsor":"The University of Hong Kong","startDate":"2015-07","conditions":"Diabetic Nephropathies","enrollment":148},{"nctId":"NCT04286399","phase":"PHASE4","title":"Asian Diabetes Outcomes Prevention Trial","status":"RECRUITING","sponsor":"National Heart Centre Singapore","startDate":"2019-07-01","conditions":"Diabetes Mellitus, Cardiovascular Diseases","enrollment":2400},{"nctId":"NCT04467931","phase":"","title":"ACEI or ARB and COVID-19 Severity and Mortality in US Veterans","status":"COMPLETED","sponsor":"University of Utah","startDate":"2020-01-19","conditions":"Hypertension, COVID","enrollment":22213},{"nctId":"NCT03695120","phase":"NA","title":"RAAS Optimization for Acute CHF Patients","status":"COMPLETED","sponsor":"University of Florida","startDate":"2019-02-08","conditions":"Acute Decompensated Heart Failure","enrollment":1},{"nctId":"NCT04842058","phase":"","title":"Pathophysiologic Hemodynamics After Primary Unilateral Total Hip Arthroplasty in Patients Receiving ACEIs and ARBs","status":"UNKNOWN","sponsor":"Hvidovre University Hospital","startDate":"2020-12-01","conditions":"Orthostatic Intolerance, Orthostatic Hypotension","enrollment":24},{"nctId":"NCT00340678","phase":"PHASE3","title":"Renoprotection in Early Diabetic Nephropathy in Pima Indians","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"1995-08","conditions":"Diabetic Nephropathy","enrollment":170},{"nctId":"NCT02648243","phase":"NA","title":"Impact of a Pharmacist-delivered Discharge and Follow-up Intervention for Patients With Acute Coronary Syndromes in Qatar","status":"COMPLETED","sponsor":"Qatar University","startDate":"2016-03-01","conditions":"Acute Coronary Syndromes","enrollment":373},{"nctId":"NCT04351724","phase":"PHASE2, PHASE3","title":"Austrian CoronaVirus Adaptive Clinical Trial (COVID-19)","status":"UNKNOWN","sponsor":"Medical University of Vienna","startDate":"2020-04-16","conditions":"COVID-19","enrollment":500},{"nctId":"NCT04218435","phase":"","title":"Impact of Sacubitril/Valsartan on Quality of Life and Mortality of CKD vs Non-CKD in Heart Failure Patients","status":"COMPLETED","sponsor":"Clinision","startDate":"2019-01-01","conditions":"Heart Failure NYHA Class IV, Heart Failure NYHA Class II","enrollment":200},{"nctId":"NCT01808196","phase":"PHASE2","title":"Testing Effectiveness of Losartan in Patients With EoE With or Without a CTD","status":"COMPLETED","sponsor":"Children's Hospital Medical Center, Cincinnati","startDate":"2013-10-10","conditions":"Eosinophilic Esophagitis, Connective Tissue Disorders","enrollment":6},{"nctId":"NCT04538924","phase":"NA","title":"Etiologic Mechanisms, Myocardial Changes and Prognosis of Patients With MINOCA","status":"UNKNOWN","sponsor":"Vilnius University Hospital Santaros Klinikos","startDate":"2019-01-01","conditions":"Myocardial Infarction With Nonobstructive Coronary Arteries","enrollment":150},{"nctId":"NCT02857309","phase":"NA","title":"Cardiac Contractility Modulation (CCM) Therapy in Subjects With Medically Refractory Heart Failure","status":"TERMINATED","sponsor":"Impulse Dynamics","startDate":"2014-02","conditions":"Heart Failure","enrollment":50},{"nctId":"NCT04510623","phase":"","title":"Host Response Mediators in Coronavirus (COVID-19) Infection","status":"UNKNOWN","sponsor":"University of British Columbia","startDate":"2020-03-17","conditions":"COVID-19, SARS-CoV2","enrollment":500},{"nctId":"NCT04357535","phase":"","title":"Prognosis of Coronavirus Disease 2019 (COVID-19) Patients Receiving Receiving Antihypertensives","status":"COMPLETED","sponsor":"Hakeam Abdulaziz Hakeam","startDate":"2020-05-10","conditions":"COVID-19","enrollment":314},{"nctId":"NCT04374695","phase":"","title":"Renin-Angiotensin-Aldosterone System Inhibitors, Hypertension, and COVID-19","status":"UNKNOWN","sponsor":"Versailles Hospital","startDate":"2020-05-01","conditions":"COVID-19","enrollment":700},{"nctId":"NCT04318301","phase":"","title":"Hypertension in Patients Hospitalized With COVID-19","status":"COMPLETED","sponsor":"Zhenhua Zen","startDate":"2020-03-21","conditions":"COVID-19, Hypertension","enrollment":275},{"nctId":"NCT00283686","phase":"PHASE3","title":"HALT Progression of Polycystic Kidney Disease Study A","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2006-01","conditions":"Kidney, Polycystic","enrollment":558},{"nctId":"NCT03284099","phase":"PHASE4","title":"Bedtime ACEIs/ARBs Versus Morning ACEIs/ARBs for Reverting Non-dipping Hypertension","status":"TERMINATED","sponsor":"Chinese University of Hong Kong","startDate":"2017-12-01","conditions":"Hypertension, Non-Dipping","enrollment":4},{"nctId":"NCT02985268","phase":"NA","title":"Evaluation of Outcomes of CRT and MitraClip for Treatment of Low Ejection Fraction and Functional Mitral Regurgitation in HF","status":"WITHDRAWN","sponsor":"Montreal Heart Institute","startDate":"2016-12","conditions":"Functional Mitral Regurgitation, Heart Failure","enrollment":""},{"nctId":"NCT04076930","phase":"","title":"Effects of Renin-Angiotensin System Inhibitors in Peritoneal Dialysis Patients","status":"UNKNOWN","sponsor":"Chiang Mai University","startDate":"2019-08-31","conditions":"Peritoneal Dialysis","enrollment":1468},{"nctId":"NCT01471860","phase":"NA","title":"BAROSTIM NEO System in the Treatment of Heart Failure","status":"UNKNOWN","sponsor":"CVRx, Inc.","startDate":"2011-08","conditions":"Heart Failure","enrollment":94}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":72,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Conventional anti-hypertensive treatment"],"phase":"marketed","status":"active","brandName":"Non-ARB","genericName":"Non-ARB","companyName":"Kyoto Prefectural University of Medicine","companyId":"kyoto-prefectural-university-of-medicine","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Non-ARB is a non-angiotensin II receptor blocker antihypertensive agent developed by Kyoto Prefectural University of Medicine. Used for Hypertension.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":true,"score":2}}